{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:38:08Z","timestamp":1793806688246,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cardiovascular disease (CVD) is the leading cause of death worldwide and a major public health concern. CVD prediction is one of the most effective measures for CVD control. In this study, 29930 subjects with high-risk of CVD were selected from 101056 people in 2014, regular follow-up was conducted using electronic health record system. Logistic regression analysis showed that nearly 30 indicators were related to CVD, including male, old age, family income, smoking, drinking, obesity, excessive waist circumference, abnormal cholesterol, abnormal low-density lipoprotein, abnormal fasting blood glucose and else. Several methods were used to build prediction model including multivariate regression model, classification and regression tree (CART), Na\u00efve Bayes, Bagged trees, Ada Boost and Random Forest. We used the multivariate regression model as a benchmark for performance evaluation (Area under the curve, AUC\u2009=\u20090.7143). The results showed that the Random Forest was superior to other methods with an AUC of 0.787 and achieved a significant improvement over the benchmark. We provided a CVD prediction model for 3-year risk assessment of CVD. It was based on a large population with high risk of CVD in eastern China using Random Forest algorithm, which would provide reference for the work of CVD prediction and treatment in China.<\/jats:p>","DOI":"10.1038\/s41598-020-62133-5","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T11:02:43Z","timestamp":1584961363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":295,"title":["Study of cardiovascular disease prediction model based on random forest in eastern China"],"prefix":"10.1038","volume":"10","author":[{"given":"Li","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinpin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4265-454X","authenticated-orcid":false,"given":"Jing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"key":"62133_CR1","unstructured":"Joint committee for the preparation of guidelines for risk assessment and management of cardiovascular diseases in China. Guidelines for risk assessment and management of cardiovascular diseases in China [J]. Chinese journal of preventive medicine. 53, 1: 13\u201335 (2019)."},{"key":"62133_CR2","first-page":"1","volume":"27","author":"M Houston","year":"2017","unstructured":"Houston, M. The role of noninvasive cardiovascular testing, applied clinical nutrition and nutritional supplements in the prevention and treatment of coronary heart disease. Ther. Adv. Cardiovasc. Dis. 27, 1\u201324 (2017).","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"issue":"5","key":"62133_CR3","doi-asserted-by":"publisher","first-page":"e0213653","DOI":"10.1371\/journal.pone.0213653","volume":"14","author":"AM AlaaID","year":"2019","unstructured":"AlaaID, A. M., Bolton, T., Angelantonio, E. D., RuddID, J. H. F. & van der Schaarl, M. Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants. PLoS One 14(5), e0213653 (2019).","journal-title":"PLoS One"},{"key":"62133_CR4","doi-asserted-by":"publisher","first-page":"e3318","DOI":"10.1136\/bmj.e3318","volume":"344","author":"GC Siontis","year":"2012","unstructured":"Siontis, G. C., Tzoulaki, I., Siontis, K. C. & Ioannidis, J. P. Comparisons of established risk prediction models for cardiovascular disease: systematic review. BMJ 344, e3318 (2012).","journal-title":"BMJ"},{"key":"62133_CR5","doi-asserted-by":"publisher","first-page":"e010200","DOI":"10.1136\/bmjopen-2015010200","volume":"6","author":"J Lu","year":"2016","unstructured":"Lu, J. et al. Protocol for the China PEACE (Patientcentered Evaluative Assessment of Cardiac Events) Million Persons Project pilot. BMJ Open. 6, e010200, https:\/\/doi.org\/10.1136\/bmjopen-2015010200 (2016).","journal-title":"BMJ Open."},{"key":"62133_CR6","unstructured":"World Health Organization. Prevention of cardiovascular disease. Guidelines for assessment and management of cardiovascular risk. Geneva: WHO (2007)."},{"issue":"1","key":"62133_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1590\/S0066-782X2009000100003","volume":"92","author":"DGD Christofaro","year":"2009","unstructured":"Christofaro, D. G. D. et al. Validation of the Omron HEM 742 Blood Pressure Monitoring Device in Adolescents. Arq. Bras. Cardiol. 92(1), 10\u201315 (2009).","journal-title":"Arq. Bras. Cardiol."},{"issue":"5","key":"62133_CR8","doi-asserted-by":"publisher","first-page":"298","DOI":"10.7326\/M18-1932","volume":"170","author":"Jiapeng Lu","year":"2019","unstructured":"J Lu, et al. Characteristics of High Cardiovascular Risk in 1.7 Million Chinese Adults. Ann. Intern. Med. 2, https:\/\/doi.org\/10.7326\/M18-1932 (2019).","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"62133_CR9","doi-asserted-by":"publisher","first-page":"e0146181","DOI":"10.1371\/journal.pone.0146181","volume":"11","author":"L Yang","year":"2016","unstructured":"Yang, L. et al. Prevalence, Awareness, Treatment, Control and Risk Factors Associated with Hypertension among Adults in Southern China, 2013. PLoS One 11(1), e0146181, https:\/\/doi.org\/10.1371\/journal.pone.0146181 (2016).","journal-title":"PLoS One"},{"key":"62133_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-903","volume":"14","author":"Y Li","year":"2014","unstructured":"Li, Y. et al. Analysis on associated factors of uncontrolled hypertension among elderly hypertensive patients in Southern China: a community based, cross-sectional survey. BMC Public. Health 14, 903, https:\/\/doi.org\/10.1186\/1471-2458-14-903 (2014).","journal-title":"BMC Public. Health"},{"key":"62133_CR11","unstructured":"Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults. Chinese Journal of Cardiology 35(5) 390\u2013419 (2007)."},{"key":"62133_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-6849-3","volume-title":"Applied Predictive Modeling","author":"Max Kuhn","year":"2013","unstructured":"Kuhn, M. & Johnson, K. Applied Predictive Modeling. Springer New York Heidelberg Dordrecht London. https:\/\/doi.org\/10.1007\/978-1-4614-6849-3."},{"issue":"14","key":"62133_CR13","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/jama.2017.12126","volume":"318","author":"AC Alba","year":"2017","unstructured":"Alba, A. C. et al. Discrimination and Calibration of Clinical Prediction Models Users\u2019Guides to the Medical Literature. JAMA 318(14), 1377\u20131384, https:\/\/doi.org\/10.1001\/jama.2017.12126 (2017).","journal-title":"JAMA"},{"key":"62133_CR14","doi-asserted-by":"publisher","first-page":"10: e1288","DOI":"10.1016\/S2214-109X(19)30365-1","volume":"7","author":"F Farzadfar","year":"2019","unstructured":"Farzadfar, F. Cardiovascular disease risk prediction models: challenges and perspectives. Lancet Glob. Health 7, 10: e1288\u2013e1289 (2019).","journal-title":"Lancet Glob. Health"},{"key":"62133_CR15","unstructured":"National Institutes of Health, National Heart, Lung, and Blood Institute. Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). 2002. https:\/\/www.healthypeople.gov\/2020\/toolsresources\/evidencebasedresource\/thirdreportexpertpaneldetectionevaluationand (accessed Aug 27, 2019)."},{"issue":"9","key":"62133_CR16","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jamainternmed.2018.3131","volume":"178","author":"GD Curfman","year":"2018","unstructured":"Curfman, G. D. Prediction of Cardiovascular Risk to Guide Primary Prevention. JAMA Intern. Med. 178(9), 1240\u20131241 (2018).","journal-title":"JAMA Intern. Med."},{"key":"62133_CR17","doi-asserted-by":"crossref","unstructured":"Basu, S., Wagner, R. G., Sewpaul, R., Reddy, P. & Davies, J. Implications of scaling up cardiovascular disease treatment in South Africa: a microsimulation and costeffectiveness analysis. Lancet Glob Health 7: e270\u201380 (2019).","DOI":"10.1016\/S2214-109X(18)30450-9"},{"issue":"375","key":"62133_CR18","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","volume":"15","author":"AV Khera","year":"2016","unstructured":"Khera, A. V. et al. Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. N. Engl. J. Med. 15(375), 2349\u20132358 (2016).","journal-title":"N. Engl. J. Med."},{"issue":"10133","key":"62133_CR19","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/S0140-6736(18)30842-0","volume":"391","author":"JAAG Damen","year":"2018","unstructured":"Damen, J. A. A. G., Hooft, L. & Moons, K. G. M. Contemporary cardiovascular risk prediction. Lancet 391(10133), 1867\u20131868 (2018).","journal-title":"Lancet"},{"issue":"25","key":"62133_CR20","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","volume":"63","author":"DC Goff Jr.","year":"2014","unstructured":"Goff, D. C. Jr. et al. ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 63(25), 2935\u20132959 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"62133_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jacc.2017.06.030","volume":"70","author":"D Lindholm","year":"2017","unstructured":"Lindholm, D. et al. Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients with Stable Coronary Disease. J. Am. Coll. cardiology 70(7), 813\u201326 (2017).","journal-title":"J. Am. Coll. cardiology"},{"issue":"29","key":"62133_CR22","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1503\/cmaj.170914","volume":"190","author":"G Douglas","year":"2018","unstructured":"Douglas, G., Manuel, M. D. & Meltem, T. Development and validation of a cardiovascular disease risk-prediction model using population health surveys: the Cardiovascular Disease Population Risk Tool (CVDPoRT). CMAJ 190(29), 871\u2013882 (2018).","journal-title":"CMAJ"},{"issue":"341","key":"62133_CR23","first-page":"132","volume":"3","author":"J Hippisley Cox","year":"2010","unstructured":"Hippisley Cox, J. et al. Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using Q Research database. BMJ 3(341), 132\u2013138 (2010).","journal-title":"BMJ"},{"issue":"3","key":"62133_CR24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1177\/2047487313516563","volume":"22","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. Lifetime risk for cardiovascular disease in a Chinese population: the Chinese Multi-Provincial Cohort Study. Eur. J. Prev. Cardiol. 22(3), 380\u2013388 (2015).","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"19","key":"62133_CR25","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/CIRCULATIONAHA.116.022367","volume":"134","author":"X Yang","year":"2016","unstructured":"Yang, X. et al. Predicting the 10\u2043Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China). Circulation 134(19), 1430\u20131440 (2016).","journal-title":"Circulation"},{"issue":"10133","key":"62133_CR26","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/S0140-6736(18)30664-0","volume":"391","author":"R Pylypchuk","year":"2018","unstructured":"Pylypchuk, R. et al. Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study. Lancet 391(10133), 1897\u20131907 (2018).","journal-title":"Lancet"},{"key":"62133_CR27","unstructured":"Institute for Health Metrics and Evaluation, University of Washington. Causes of death visualization. https:\/\/vizhub.healthdata.org\/cod\/ (accessed Jan 24, 2018)."},{"key":"62133_CR28","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1136\/hrt.2010.220442","volume":"97","author":"SM Liew","year":"2011","unstructured":"Liew, S. M., Doust, J. & Glasziou, P. Cardiovascular risk scores do not account for the effect of treatment: a review. Heart 97, 689\u201397 (2011).","journal-title":"Heart"},{"key":"62133_CR29","doi-asserted-by":"publisher","first-page":"i2416","DOI":"10.1136\/bmj.i2416","volume":"353","author":"JA Damen","year":"2016","unstructured":"Damen, J. A. et al. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ 353, i2416 (2016).","journal-title":"BMJ"},{"issue":"25 suppl 2","key":"62133_CR30","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","volume":"129","author":"DC Goff Jr","year":"2014","unstructured":"Goff, D. C. Jr et al. ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation 129(25 suppl 2), S49\u201373 (2014).","journal-title":"Circulation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62133-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62133-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62133-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:28:24Z","timestamp":1670315304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62133-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,23]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["62133"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-62133-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,23]]},"assertion":[{"value":"20 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5245"}}